Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2005
09/15/2005US20050201946 Intranasal influenza virus vaccine
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005CA2812132A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2560066A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2558813A1 Pharmaceutical composition comprising cxcr3 inhibitor
09/15/2005CA2558721A1 Screening method for emulators of neural activity and digestive system using gpr35
09/15/2005CA2558670A1 Methods of evaluating efficacy of an immune response by assessing alpha-1 integrin expression
09/15/2005CA2558660A1 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
09/15/2005CA2558586A1 Recombinant varicella-zoster virus
09/15/2005CA2558408A1 Compositions and methods for topical application and transdermal delivery of botulinum toxins
09/15/2005CA2558399A1 Partially loaded antibodies and methods of their conjugation
09/15/2005CA2558382A1 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
09/15/2005CA2558379A1 Multi-component biological transport systems
09/15/2005CA2557953A1 Preparation of recombinant rotavirus proteins in milk of transgenic non human mammals
09/15/2005CA2557876A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
09/15/2005CA2557654A1 Peptides of il1 beta and tnf alpha and method of treatment using same
09/15/2005CA2557353A1 Immunogenic compositions for chlamydia pneunomiae
09/15/2005CA2555612A1 Compositions and methods for the treatment and clinical remission of psoriasis
09/15/2005CA2500926A1 Tumor/b-cell hybrid cells and uses thereof
09/14/2005EP1574579A2 Outer surface proteins, their genes, and their use
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574517A1 HCV E1 comprising specific disulfide bridges
09/14/2005EP1574217A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants
09/14/2005EP1574209A1 Device and method for treating ophthalmic diseases
09/14/2005EP1573071A2 Methods for detecting invasion of a cell
09/14/2005EP1573069A2 Amplified cancer target genes useful in diagnosis and therapeutic screening
09/14/2005EP1573048A2 Breast specific protein expressed in cancer and methods of use thereof
09/14/2005EP1573047A2 Lectin compositions and methods for modulating an immune response to an antigen
09/14/2005EP1573038A2 A high resolution typing system for pathogenic mycobacterium tuberculosum
09/14/2005EP1573035A2 Brother of the regulator of imprinted sites (boris)
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573014A2 Immunization of fish with plant-expressed recombinant proteins
09/14/2005EP1573012A1 Recombinant viral-based malaria vaccines
09/14/2005EP1572985A1 Production of alvac on avian embryonic stem cells
09/14/2005EP1572976A2 Modulating immune responses
09/14/2005EP1572975A2 Streptococcus uberis adhesion molecule
09/14/2005EP1572972A2 Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies
09/14/2005EP1572963A2 Carbohydrate-based synthetic vaccines for hiv
09/14/2005EP1572950A2 Single domain tdf-related compounds and analogs thereof
09/14/2005EP1572947A2 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
09/14/2005EP1572946A2 Therapeutic human anti-il-1r1 monoclonal antibody
09/14/2005EP1572944A2 Methods and compositions for modulating xbp-1 activity
09/14/2005EP1572943A2 Circular nucleic acid vectors, and methods for making and using the same
09/14/2005EP1572942A2 Live replicating spumavirus vector
09/14/2005EP1572941A2 Novel flavivirus antigens
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572931A2 Methods and compositions for modulating and detecting wisp activity
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572925A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572918A2 Synthetic glyco-lipo-peptides as vaccines
09/14/2005EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
09/14/2005EP1572915A2 Preservation of bioactive materials by spray drying
09/14/2005EP1572910A2 Signal for packaging of influenza virus vectors
09/14/2005EP1572909A2 A follistatin domain containing protein
09/14/2005EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
09/14/2005EP1572905A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572894A2 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572744A2 Immunoglobulin variants and uses thereof
09/14/2005EP1572742A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
09/14/2005EP1572731A2 A method for the production of hiv-1 gag virus-like particles
09/14/2005EP1572730A2 Nact as a target for lifespan expansion and weight reduction
09/14/2005EP1572729A2 Mutant protein and refolding method
09/14/2005EP1572721A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572341A2 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
09/14/2005EP1572235A2 Methods of therapy and diagnosis using targeting of cells that express lax
09/14/2005EP1572233A1 Hpv-16 and -18 l1 vlp vaccine
09/14/2005EP1572232A1 Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum
09/14/2005EP1572231A2 Cancer immunotherapy using polycomb proteins
09/14/2005EP1572224A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor
09/14/2005EP1572170A2 Immunotoxin as a therapeutic agent and uses thereof
09/14/2005EP1572149A2 Immunogenicity of glucan binding protein
09/14/2005EP1572131A2 Antibody therapy
09/14/2005EP1572125A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/14/2005EP1572121A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/14/2005EP1572116A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572108A2 Functional mutations in respiratory syncytial virus
09/14/2005EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
09/14/2005EP1572103A2 Anti-angiogenic uses of il-6 antagonists
09/14/2005EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
09/14/2005EP1572101A2 Disease treatment via antimicrobial peptide inhibitors
09/14/2005EP1572100A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
09/14/2005EP1572090A2 Cancer vaccine containing cross-species epitopes of telomerase reverse transcriptase
09/14/2005EP1572087A2 Antibodies against cancer antigen tmeff2 and uses thereof
09/14/2005EP1572083A2 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
09/14/2005EP1572077A2 Uses of monoclonal antibody 8h9
09/14/2005EP1572075A2 Method for treating diseases associated with abnormal kinase activity
09/14/2005EP1572074A2 Stabilized synthetic immunogen delivery system
1 ... 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 ... 1823